The RAPID TRANSLATION AWARD honors a public-private partnership that has made a critical contribution to public health progress. This award is part of the suite of Outstanding Achievement in Public Health Awards, generously supported by Johnson & Johnson.
Medicines for Malaria Venture (MMV) and its partners’ groundbreaking research has led to the approval of 19 malaria medicines. The medicines supported by MMV have treated or protected 1.5 billion people. Martin Fitchet, Chief Executive Officer, will accept on behalf of this organization.
Learn more about the Outstanding Achievement in Public Health Awards, generously supported by Johnson & Johnson.
